Toxicology Handbook. (2022)
- Record Type:
- Book
- Title:
- Toxicology Handbook. (2022)
- Main Title:
- Toxicology Handbook
- Further Information:
- Note: Jason Armstrong, Ovidiu Pascu.
- Authors:
- Armstrong, Jason
Pascu, Ovidiu - Contents:
- CHAPTER 1 APPROACH TO THE POISONED PATIENT 1.1 Overview 1.2 Resuscitation 1.3 Risk assessment 1.4 Supportive care and monitoring 1.5 Investigations 1.6 Gastrointestinal decontamination 1.7 Enhanced elimination 1.8 Antidotes 1.9 Description CHAPTER 2 SPECIFIC CONSIDERATIONS 2.1 Coma 2.2 Hypotension 2.3 Seizures 2.4 Approach to delirium 2.5 Serotonin toxicity 2.6 Anticholinergic toxicity 2.7 Cholinergic toxicity 2.8 Neuroleptic malignant syndrome 2.9 Alcohol use disorder 2.10 Amphetamine use disorder 2.11 Opioid use disorder 2.12 Sedative-hypnotic use disorder 2.13 Solvent abuse 2.14 Body packers and stuffers 2.15 Osmolar gap 2.16 Acid–base disorders 2.17 The 12-lead ECG in toxicology 2.18 Approach to mushroom poisoning 2.19 Approach to plant poisoning 2.20 Poisoning during pregnancy and lactation 2.21 Poisoning in children 2.22 Poisoning in the elderly CHAPTER 3 SPECIFIC TOXINS 3.1 Alcohol: Ethanol 3.2 Alcohol: Ethylene glycol 3.3 Alcohol: Isopropanol (isopropyl alcohol) 3.4 Alcohol: Methanol (methyl alcohol) 3.5 Alcohol: Other toxic alcohols 3.6 Amisulpride 3.7 Amphetamines and amphetamine-like substances 3.8 Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) 3.9 Anticoagulant rodenticides 3.10 Anticonvulsants: Newer agents 3.11 Antihistamines (non-sedating) 3.12 Antihistamines (sedating) 3.13 Arsenic 3.14 Baclofen 3.15 Barbiturates 3.16 Benzodiazepines 3.17 Benztropine 3.18 Beta-blockers 3.19 Bupropion 3.20 Button batteries 3.21CHAPTER 1 APPROACH TO THE POISONED PATIENT 1.1 Overview 1.2 Resuscitation 1.3 Risk assessment 1.4 Supportive care and monitoring 1.5 Investigations 1.6 Gastrointestinal decontamination 1.7 Enhanced elimination 1.8 Antidotes 1.9 Description CHAPTER 2 SPECIFIC CONSIDERATIONS 2.1 Coma 2.2 Hypotension 2.3 Seizures 2.4 Approach to delirium 2.5 Serotonin toxicity 2.6 Anticholinergic toxicity 2.7 Cholinergic toxicity 2.8 Neuroleptic malignant syndrome 2.9 Alcohol use disorder 2.10 Amphetamine use disorder 2.11 Opioid use disorder 2.12 Sedative-hypnotic use disorder 2.13 Solvent abuse 2.14 Body packers and stuffers 2.15 Osmolar gap 2.16 Acid–base disorders 2.17 The 12-lead ECG in toxicology 2.18 Approach to mushroom poisoning 2.19 Approach to plant poisoning 2.20 Poisoning during pregnancy and lactation 2.21 Poisoning in children 2.22 Poisoning in the elderly CHAPTER 3 SPECIFIC TOXINS 3.1 Alcohol: Ethanol 3.2 Alcohol: Ethylene glycol 3.3 Alcohol: Isopropanol (isopropyl alcohol) 3.4 Alcohol: Methanol (methyl alcohol) 3.5 Alcohol: Other toxic alcohols 3.6 Amisulpride 3.7 Amphetamines and amphetamine-like substances 3.8 Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) 3.9 Anticoagulant rodenticides 3.10 Anticonvulsants: Newer agents 3.11 Antihistamines (non-sedating) 3.12 Antihistamines (sedating) 3.13 Arsenic 3.14 Baclofen 3.15 Barbiturates 3.16 Benzodiazepines 3.17 Benztropine 3.18 Beta-blockers 3.19 Bupropion 3.20 Button batteries 3.21 Calcium channel blockers (CCBs) 3.22 Cannabinoids and synthetic cannabinoid receptor agonists (SCRAs) 3.23 Carbamazepine 3.24 Carbon monoxide 3.25 Chloroquine and hydroxychloroquine 3.26 Chloral hydrate 3.27 Clonidine and other central ?2-adrenergic agonists 3.28 Clozapine 3.29 Cocaine 3.30 Colchicine 3.31 Corrosives 3.32 Cyanide 3.33 Digoxin: Acute overdose 3.34 Digoxin: Chronic poisoning 3.35 Diphenoxylate–atropine 3.36 Direct oral anticoagulants 3.37 Gamma-hydroxybutyrate (GHB) 3.38 Glyphosate 3.39 Hydrocarbons 3.40 Hydrofluoric acid 3.41 Hydrogen peroxide 3.42 Insulin 3.43 Iron 3.44 Isoniazid 3.45 Lamotrigine 3.46 Lead 3.47 Lithium: Acute overdose 3.48 Lithium: Chronic poisoning 3.49 Local anaesthetic agents 3.50 Mercury 3.51 Metformin 3.52 Methotrexate 3.53 Mirtazapine 3.54 Monoamine oxidase inhibitors (MAOIs) 3.55 Non-steroidal anti-inflammatory drugs (NSAIDs) 3.56 Olanzapine 3.57 Opioids 3.58 Organochlorines 3.59 Organophosphorus agents (organophosphates and carbamates) 3.60 Paracetamol: Immediate-release preparations (acute overdose) 3.61 Paracetamol: Modified-release formulations 3.62 Paracetamol: Repeated supratherapeutic ingestion 3.63 Paraquat 3.64 Phenothiazines and butyrophenones (antipsychotic agents) 3.65 Phenytoin 3.66 Potassium chloride 3.67 Pregabalin 3.68 Quetiapine 3.69 Quinine 3.70 Risperidone 3.71 Salicylates 3.72 Selective serotonin reuptake inhibitors (SSRIs) 3.73 Strychnine 3.74 Sulfonylureas 3.75 Theophylline 3.76 Thyroxine 3.77 Tramadol and tapentadol 3.78 Tricyclic antidepressants (TCAs) 3.79 Valproic acid (sodium valproate) 3.80 Venlafaxine and desvenlafaxine 3.81 Warfarin CHAPTER 4 ANTIDOTES 4.1 Atropine 4.2 Calcium 4.3 Cyproheptadine 4.4 Desferrioxamine 4.5 Digoxin immune fab 4.6 Dimercaprol 4.7 DMSA (succimer) and DMPS (unithiol) 4.8 Ethanol 4.9 Flumazenil 4.10 Folinic acid 4.11 Fomepizole 4.12 Glucose 4.13 Hydroxocobalamin 4.14 Insulin (high-dose) 4.15 Intravenous lipid emulsion 4.16 Methylene blue 4.17 N-acetylcysteine 4.18 Naloxone 4.19 Octreotide 4.20 Penicillamine 4.21 Physostigmine 4.22 Pralidoxime 4.23 Pyridoxine 4.24 Sodium bicarbonate 4.25 Sodium calcium edetate 4.26 Sodium thiosulfate 4.27 Vitamin K CHAPTER 5 ENVENOMINGS 5.1 Approach to snakebite 5.2 Black snake 5.3 Brown snake 5.4 Death adder 5.5 Tiger snake group 5.6 Taipan 5.7 Sea snakes 5.8 Australian scorpions 5.9 Bluebottle jellyfish (Physalia species) 5.10 Stonefish 5.11 Box jellyfish 5.12 Irukandji syndrome 5.13 Blue-ringed octopus 5.14 Redback spider 5.15 Funnel-web (big black) spider 5.16 White-tailed spider 5.17 Ticks CHAPTER 6 ANTIVENOMS 6.1 Black Snake Antivenom 6.2 Brown Snake Antivenom 6.3 Death Adder Antivenom 6.4 Tiger Snake Antivenom 6.5 Taipan Antivenom 6.6 Sea Snake Antivenom 6.7 Polyvalent Snake Antivenom 6.8 Stonefish Antivenom 6.9 Box Jellyfish Antivenom 6.10 Redback Spider Antivenom 6.11 Funnel-Web Spider Antivenom 6.12 Allergic Reactions to Antivenom … (more)
- Edition:
- 4th
- Publisher Details:
- Elsevier
- Publication Date:
- 2022
- Extent:
- 1 online resource (560 pages)
- Languages:
- English
- ISBNs:
- 9780729589314
0729589315 - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.748195
- Ingest File:
- 16_011.xml